Sk Biopharmaceutica Correlations

326030 Stock

97,700 3,200 3.17%

The current 90-days correlation between Sk Biopharmaceuticals and Korea Information Communications is 0.15 (i.e., Average diversification). The correlation of Sk Biopharmaceutica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Sk Biopharmaceutica Correlation With Market

Good diversification

The correlation between Sk Biopharmaceuticals Co and DJI is -0.04 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sk Biopharmaceuticals Co and DJI in the same portfolio, assuming nothing else is changed.

The ability to find closely correlated positions to Sk Biopharmaceutica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sk Biopharmaceutica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sk Biopharmaceutica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sk Biopharmaceuticals Co to buy it.

Moving together with 326030 Stock

0.66	207940	Samsung Biologics	Pair Corr
0.9	298380	ABL Bio	Pair Corr
0.72	144510	Green Cross Lab	Pair Corr
0.82	334970	Prestige Biologics	Pair Corr
0.67	226950	OliX PharmaceuticalsInc	Pair Corr

Moving against 326030 Stock

0.37

182360

Cube Entertainment

Pair Corr

Related Correlations Analysis

	025770	010280	071055	019550	036800	000400	277070
025770		0.25	-0.5	0.45	0.61	0.59	0.63	025770
010280	0.25		-0.18	0.27	-0.25	-0.13	-0.13	010280
071055	-0.5	-0.18		-0.63	-0.45	-0.62	-0.64	071055
019550	0.45	0.27	-0.63		0.38	0.6	0.52	019550
036800	0.61	-0.25	-0.45	0.38		0.89	0.9	036800
000400	0.59	-0.13	-0.62	0.6	0.89		0.89	000400
277070	0.63	-0.13	-0.64	0.52	0.9	0.89		277070
	025770	010280	071055	019550	036800	000400	277070

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

277070	+ 0.9	036800
000400	+ 0.89	036800
277070	+ 0.89	000400
277070	+ 0.63	025770
036800	+ 0.61	025770
000400	+ 0.6	019550

High negative correlations

277070	- 0.64	071055
019550	- 0.63	071055
000400	- 0.62	071055
071055	- 0.5	025770
036800	- 0.45	071055
036800	- 0.25	010280

Risk-Adjusted Indicators

There is a big difference between 326030 Stock performing well and Sk Biopharmaceutica Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sk Biopharmaceutica's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
025770	0.91	0.04	(0.09)	(0.04)	1.09	(1.05)	2.23	(1.77)	6.76
010280	0.86	0.06	(0.07)	(0.32)	0.93	(1.03)	1.64	(1.32)	5.21
071055	0.91	0.08	(0.03)	(8.57)	1.02	(1.10)	1.80	(1.38)	5.52
019550	1.85	(0.08)	0.00	(0.55)	0.00	0.00	3.97	(4.18)	10.21
036800	0.45	(0.13)	0.00	(0.97)	0.00	0.00	0.80	(0.95)	2.94
000400	1.79	(0.44)	0.00	39.93	0.00	0.00	3.39	(3.70)	11.89
277070	1.72	(0.58)	0.00	(0.85)	0.00	0.00	3.05	(6.09)	16.59

Be your own money manager

Our tools can tell you how much better you can do entering a position in Sk Biopharmaceutica without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Analyzer Now

Portfolio Analyzer

Portfolio analysis module that provides access to portfolio diagnostics and optimization engine

All Next

Launch Module

Sk Biopharmaceutica Corporate Management

Elected by the shareholders, the Sk Biopharmaceutica's board of directors comprises two types of representatives: Sk Biopharmaceutica inside directors who are chosen from within the company, and outside directors, selected externally and held independent of 326030. The board's role is to monitor Sk Biopharmaceutica's management team and ensure that shareholders' interests are well served. Sk Biopharmaceutica's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sk Biopharmaceutica's outside directors are responsible for providing unbiased perspectives on the board's policies.

Wanho Nam	VP HR	Profile
Sungwan Hwang	VP Innovation	Profile
Jooyup Chae	VP Counsel	Profile
HyungRae Cho	F Exec	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC